GMMDC member Grace Medical, which specializes in ENT implants, and Hurricane Medical, a maker of single-use ophthalmic products, were acquired by Innovia Medical, backed by Inverness Graham. The acquisitions expand Innovia’s surgical portfolio, manufacturing capabilities, and global reach. Leadership from both companies will remain in place, supporting Innovia’s vision of building an integrated platform that advances patient care worldwide.

Join us on March 16th from 12-5 PM at The Brass Door in Memphis for an exciting St. Patrick’s Day Party celebrating the launch of Hania Skin Protectant! Enjoy live music, themed cocktails, and Irish sports activities while taking part in fun contests like the Best Dressed Competition and Leprechaun Hunt for a chance to win cash prizes. The first 30 guests will receive exclusive goody bags, and there will be huge giveaways, including an Aer Lingus flight voucher worth $2000, a signed Irish rugby jersey, and authentic Irish goodies. Don’t miss this lively celebration of Irish culture—see you there!

Biomimetic Innovations signed an exclusive U.S. license and distribution agreement with Sanara MedTech for its FDA Breakthrough Device, OsStic®, a synthetic bio-adhesive bone filler. Sanara will make a minority equity investment and gain exclusive rights, aiming to accelerate U.S. commercialization and improve outcomes in fracture repair.

The orthopedic elite celebrated a banner year in fiscal 2023; no company in the top 10 list reported revenue loss. The reason cited by most was the long-heralded return of elective surgery pacing, after the pandemic caused a dearth in those procedures.

Smith+Nephew launched a global Advisory Board under its Orthopaedics for All initiative to promote diversity in orthopedic surgery. With women making up only 15% of residents and 7.4% of surgeons in 2022, the board will work to tackle barriers like work-family conflict, limited mentorship, and funding gaps, aiming to inspire inclusion and set new care standards.

Earlier this week, Reinhardt and four other patients with artificial ankles shared their experiences at a town-hall-style summit held at Stryker Corp.’s Arlington campus. The event featured an array of patients from Reinhardt to a local cyclist and former police-department leader who needed the procedure to continue exercising.

Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is: OsStic® Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects to enhance structural stability where standard fixation alone cannot provide sufficient support for functional mobilization.

The company’s transformation into a global player is a testament to entrepreneurial spirit, technological innovation, and dedication to customer service.

FDA greenlights medical device to combat bladder issues In the latest edition of STAT's Health Tech newsletter: the FDA greenlights device to combat bladder issues and telehealth companies court payers looking for weight loss programs.

Researchers at the University of Leeds in the UK have developed a magnetic tentacle robot that is intended for use in minimally invasive medical procedures, such as the treatment of tumors in the lungs.

The FDA issued healthcare providers updated guidance for certain warning language with paclitaxel-coated devices that treat PAD.

Moximed, a medtech company based in California, has developed the MISHA knee system, an implantable shock absorber for use in patients with knee osteoarthritis.

Cala Health recently launched its kIQ system — which it calls the first noninvasive wearable device cleared by the FDA to temporarily relieve tremors in people with essential tremor and Parkinson’s disease.

The device is indicated for both anatomic and reverse total shoulder arthroplasty.

The company announced the first-in-human implant of its Masa valve, saying the device could be a significant improvement in the treatment of pediatric cardiovascular congenital heart defects.

“It’s a setback in patient safety and surveillance,” one expert said, "and will leave us with an insufficient regulatory system for identifying unsafe devices."

IME East panel to explore the issues of attracting younger workers to the dynamic, high-tech manufacturing sector.